Jan 11, 2021
Elicera Therapeutics recruits CFO
Read moreJan 8, 2021
Elicera Therapeutics invitation to company presentation (in Swedish)
Read moreOct 5, 2020
Elicera Therapeutics completes oversubscribed share issue and launches unique immuno-oncology company with focus on CAR T-cells and oncolytic viruses
Read more